Form D · Pharmaceuticals

RESPIRICS INC

Raleigh, NC · CIK 0001287016

Offering snapshot reported Aug 27, 2010 · SEC filing

Reported sold
$146K
Offering amount: $146K
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 27, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 27, 2010Initial$146,257No comparison13SEC filing
May 4, 2010Initial$3,726,283No comparison50SEC filing
Sep 11, 2009Initial$375,000No comparison10SEC filing
Feb 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Sep 6, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-147046

Source: Form D, filed Aug 27, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Q Adams Sr. Director
John Q Adams, Sr. Director
James R Butler Director, Executive
Robert A Casper Director
Mark Celeste Director, Executive
R. Brent Dixon Director
R Brent Dixon Director
Brent R Dixon Director
David L Gardner Executive
Gilbert Mott Director
Lary Snodgras Director
Lary Snodgrass Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
6008 Triangle Dr Ste 101
Raleigh, NC, 27617